BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kelso M, Weideman RA, Cipher DJ, Feagins LA. Factors Associated With Length of Stay in Veterans With Inflammatory Bowel Disease Hospitalized for an Acute Flare. Inflamm Bowel Dis 2017;24:5-11. [PMID: 29272483 DOI: 10.1093/ibd/izx020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Wickramasinghe D, Adegbola S, Sahnan K, Morar P, Carvello M, Di Candido F, Maroli A, Spinelli A, Warusavitarne J. A scoring system to predict a prolonged length of stay after surgery for Crohn's disease. Colorectal Dis 2021;23:1205-12. [PMID: 33539619 DOI: 10.1111/codi.15567] [Reference Citation Analysis]
2 Verma A, Varma S, Freedberg DE, Axelrad JE. A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease. Dig Dis Sci 2021. [PMID: 33606139 DOI: 10.1007/s10620-021-06877-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sheehan JL, Jacob J, Berinstein EM, Greene-Higgs L, Steiner CA, Berry SK, Shannon C, Cohen-Mekelburg SA, Higgins PDR, Berinstein JA. The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis 2022:izac021. [PMID: 35230420 DOI: 10.1093/ibd/izac021] [Reference Citation Analysis]
4 Soriano CR, Powell CR, Chiorean MV, Simianu VV. Role of hospitalization for inflammatory bowel disease in the post-biologic era. World J Clin Cases 2021; 9(26): 7632-7642 [PMID: 34621815 DOI: 10.12998/wjcc.v9.i26.7632] [Reference Citation Analysis]
5 Luo L, Xu X, Jiang Y, Zhu W. Predicting Intracerebral Hemorrhage Patients' Length-of-Stay Probability Distribution Based on Demographic, Clinical, Admission Diagnosis, and Surgery Information. J Healthc Eng 2019;2019:4571636. [PMID: 30809336 DOI: 10.1155/2019/4571636] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Le Berre C, Peyrin-Biroulet L; SPIRIT-IOIBD study group. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD. Gastroenterology 2021;160:1452-1460.e21. [PMID: 33421515 DOI: 10.1053/j.gastro.2020.10.065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]